Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC) Trading 1.1% Higher

Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC)’s stock price shot up 1.1% on Friday . The stock traded as high as $33.17 and last traded at $33.10, 300 shares changed hands during mid-day trading. A decline of 95% from the average session volume of 6,093 shares. The stock had previously closed at $32.74.

The company’s 50 day moving average price is $28.29 and its two-hundred day moving average price is $27.24.

In other Virtus LifeSci Biotech Clinical Trials ETF news, insider Sutton Jon purchased 60,000 shares of the company’s stock in a transaction dated Monday, November 11th. The shares were acquired at an average price of $0.63 per share, for a total transaction of $37,800.00.

Featured Story: How To Calculate Debt-to-Equity Ratio

Receive News & Ratings for Virtus LifeSci Biotech Clinical Trials ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Virtus LifeSci Biotech Clinical Trials ETF and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit